Monday, November 19, 2012

14th Annual Immunogenicity for Biotherapeutics: Agenda now Available

For the 14th year in a row, IIR’s Immunogenicity for Biotherapeutics conference provides unique knowledge-sharing opportunities that will help remove the uncertainty surrounding immune response prediction and minimization. We are continuing to help our audience design reliable, predictable, worthwhile tests that can help guarantee biologic safety.

This year’s agenda offers case studies that bridge both ever-present challenges of assay design and advanced de-risking strategies for the next generation of biomolecules. Our faculty helps you:
  • • Optimize your risk minimization strategies to cover the entire preclinical-to-clinical life cycle
  • • Create and capitalize on the most advanced transgenic animal models to get the best grasp on predicting immunogenicity
  • • Identify the must-have features of molecular design to minimize or eliminate epitopes
  • • Adapt your skills to the unique features of newly-developed varieties of biomolecules, including biosimilars, nanomedicines, bispecifics and antibody-drug conjugates

PLUS! Based on feedback from your industry peers, our 2013 agenda highlights include:
  • • Three FDA keynote speakers - An in-depth insight from FDA regulators, featuring the release of draft guidelines for biosimilar development
  • • Immunogenicity University - Back by popular demand, this intensive full-day summit dives into the fundamentals of immunogenicity assessment, statistical analysis and assay design – beneficial for experts at all levels of their career
  • • Increased Networking Opportunities - You’ll have 8+ hours of networking opportunity, including a Wine and Cheese Reception where scientists can link-up with lab technicians, research providers and regulatory consultants
The Immunogenicity for Biotherapeutics Conference is taking place March 18-20, 2013, in Baltimore, MD. As a reader of this blog, you receive an exclusive discount of 15% off the standard rate when you register using code XP1838Link. If you have any questions about the agenda, feel free to contact Jennifer Pereira.

Share this article with your social network, just click below to share now!

No comments :

Post a Comment